Literature DB >> 26574143

Elevated H2 O2 levels in trinitrobenzene sulfate-induced colitis rats contributes to visceral hyperalgesia through interaction with the transient receptor potential ankyrin 1 cation channel.

Yoko Kogure1, Shenglan Wang1,2, Koh-Ichi Tanaka1, Yongbiao Hao1, Satoshi Yamamoto1, Nobuyoshi Nishiyama1, Koichi Noguchi2,3, Yi Dai1,2,3.   

Abstract

BACKGROUND AND AIM: Inflammatory bowel disease is associated with chronic abdominal pain. Transient receptor potential ankyrin 1 (TRPA1) is a well-known pain sensor expressed in primary sensory neurons. Recent studies indicate that reactive oxygen species such as hydrogen peroxide (H2 O2 ) may activate TRPA1.
METHODS: Colonic inflammation was induced by intra-colonic administration of trinitrobenzene sulfate (TNBS) in adult male Sprague-Dawley rats. Visceromotor response (VMR) to colorectal distention (CRD) was recorded to evaluate the visceral hyperalgesia. Rats were sacrificed 1 day after treatment with saline or TNBS; colonic tissues from the inflamed region were removed and then processed to assess the H2 O2 content. H2 O2 scavenger N-acetyl-l-cysteine or a TRPA1 antagonist, HC-030031, was intravenously administrated to the TNBS-treated rats or saline-treated rats. In a parallel experiment, intra-colonic H2 O2 -induced visceral hyperalgesia in naïve rats and the effect of intravenous HC-030031 were measured based on the VMR to CRD.
RESULTS: Trinitrobenzene sulfate treatment resulted in significant increase in VMR to CRD at day 1. The H2 O2 content in the inflamed region of the colon in TNBS-treated rats was significantly higher than that of saline-treated rats. N-acetyl-l-cysteine or HC-030031 significantly suppressed the enhanced VMR in TNBS-treated rats while saline-treated rats remained unaffected. Moreover, blockade of TRPA1 activation by HC-030031 significantly reversed the exogenous H2 O2 -induced visceral hyperalgesia.
CONCLUSION: These results suggest that H2 O2 content of the colonic tissue is increased in the early stage of TNBS-induced colitis. The increased H2 O2 content may contribute to the visceral hyperalgesia by activating TRPA1.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  H2O2; IBD; TNBS; TRPA1; visceral pain

Mesh:

Substances:

Year:  2016        PMID: 26574143     DOI: 10.1111/jgh.13226

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  TRPA1-expressing lamina propria mesenchymal cells regulate colonic motility.

Authors:  Yanjing Yang; Shenglan Wang; Kimiko Kobayashi; Yongbiao Hao; Hirosato Kanda; Takashi Kondo; Yoko Kogure; Hiroki Yamanaka; Satoshi Yamamoto; Junxiang Li; Hiroto Miwa; Koichi Noguchi; Yi Dai
Journal:  JCI Insight       Date:  2019-05-02

Review 2.  TRPA1 Role in Inflammatory Disorders: What Is Known So Far?

Authors:  Lorenzo Landini; Daniel Souza Monteiro de Araujo; Mustafa Titiz; Pierangelo Geppetti; Romina Nassini; Francesco De Logu
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats.

Authors:  Sonya G Lehto; Andy D Weyer; Beth D Youngblood; Maosheng Zhang; Ruoyuan Yin; Weiya Wang; Yohannes Teffera; Melanie Cooke; Cheryl L Stucky; Laurie Schenkel; Stephanie Geuns-Meyer; Bryan D Moyer; Kenneth D Wild; Narender R Gavva
Journal:  Mol Pain       Date:  2016-11-29       Impact factor: 3.395

Review 4.  Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?

Authors:  Simona Giorgi; Magdalena Nikolaeva-Koleva; David Alarcón-Alarcón; Laura Butrón; Sara González-Rodríguez
Journal:  Int J Mol Sci       Date:  2019-06-14       Impact factor: 5.923

5.  Pain matrix shift in the rat brain following persistent colonic inflammation revealed by voxel-based statistical analysis.

Authors:  Tianliang Huang; Takashi Okauchi; Di Hu; Mika Shigeta; Yuping Wu; Yasuhiro Wada; Emi Hayashinaka; Shenglan Wang; Yoko Kogure; Koichi Noguchi; Yasuyoshi Watanabe; Yi Dai; Yilong Cui
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

6.  Daikenchuto attenuates visceral pain and suppresses eosinophil infiltration in inflammatory bowel disease in murine models.

Authors:  Yoko Kogure; Hirosato Kanda; Shenglan Wang; Yongbiao Hao; Junxiang Li; Satoshi Yamamoto; Koichi Noguchi; Yi Dai
Journal:  JGH Open       Date:  2020-08-22

7.  Intrarectal Capsazepine Administration Modulates Colonic Mucosal Health in Mice.

Authors:  Vibhu Kumar; Vijay Kumar; Kirti Devi; Ajay Kumar; Rehan Khan; Ravindra Pal Singh; Sivasubramanian Rajarammohan; Kanthi Kiran Kondepudi; Kanwaljit Chopra; Mahendra Bishnoi
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

Review 8.  Transient Receptor Potential Channels and Inflammatory Bowel Disease.

Authors:  Yiding Chen; Jingxi Mu; Min Zhu; Arjudeb Mukherjee; Hu Zhang
Journal:  Front Immunol       Date:  2020-02-20       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.